Cardiometabolic Risk
Cardiometabolic Risk
07/25/2016
New research examined the categorical and quantitative dose-response association between sedentary behavior and CVD risk.
07/25/2016
Cardiometabolic Risk
Cardiometabolic Risk
07/20/2016
A recent study compared efficacy and safety of 9 available glucose-lowering drugs for the treatment of type 2 diabetes.
07/20/2016
Cardiometabolic Risk
Cardiometabolic Risk
07/19/2016
A recent study assessed the effects of visit-to-visit low-density lipoprotein cholesterol variability, independent of mean LDL-C, on cognitive performance and white matter hyperintensity load.
07/19/2016
Cardiometabolic Risk
Cardiometabolic Risk
06/23/2016
A recent study examined the relationship between body mass index in young men and the risk of hospitalization with heart failure later in life.
06/23/2016
Cardiometabolic Risk
Cardiometabolic Risk
05/23/2016
Endoscopic approaches to gastric remodeling are safe and effective ways to induce long-term weight loss, according to the results of 2 recent studies.
05/23/2016
Cardiometabolic Risk
Cardiometabolic Risk
05/09/2016
A recent study examined the potential use of blood pressure trajectories rather than single or average BP levels in the prediction of stroke and mortality risk.
05/09/2016
Cardiometabolic Risk
Cardiometabolic Risk
05/02/2016
A study examined how certain dietary patterns influence the risk of adverse cardiovascular event in patients with coronary heart disease, and whether it is more important to eat healthy foods or to avoid...
05/02/2016
Cardiometabolic Risk
Cardiometabolic Risk
04/29/2016
A new study examined the potential benefits of brief intervals of vigorous exercise compared with traditional endurance training.
04/29/2016
Cardiometabolic Risk
Cardiometabolic Risk
04/11/2016
Two new studies explored the impact of exercise on patients with atrial fibrillation.
04/11/2016
Cardiometabolic Risk
Cardiometabolic Risk
04/08/2016
Michael J. Bloch, MD; B. Alan Bottenberg, DO
Recently, therapy to reduce PCSK9 activity has been approved for use in those with cardiovascular disease who require additional LDL-C lowering despite the use of maximally tolerated statins.
04/08/2016